Form4insider filings, from the source

Insider · CIK 0001920738

Scott Bizily

Files at: FDMT. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $280k · 5net −$280k
$10k$10k$100k$100k$1M$1MbuyssalesJun 22Jul 6Jul 21Aug 4Aug 19Sep 2Sep 17

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Sep 16, 2026 SForm 4 →Sep 22, 6:43 pm EDT4D Molecular Therapeutics, Inc.FDMT1,635$13.65$22,3188,617−15.9%10b5-1 late
Sep 16, 2026 MForm 4 →Sep 22, 6:43 pm EDT4D Molecular Therapeutics, Inc.FDMT1,635$4.14$6,76910,252—10b5-1 late
Sep 1, 2026 SForm 4 →Sep 3, 6:55 pm EDT4D Molecular Therapeutics, Inc.FDMT584$14.00$8,1768,617−6.35%10b5-1
Sep 1, 2026 MForm 4 →Sep 3, 6:55 pm EDT4D Molecular Therapeutics, Inc.FDMT584$6.49$3,7909,201—10b5-1
Aug 13, 2026 SForm 4 →Aug 17, 5:34 pm EDT4D Molecular Therapeutics, Inc.FDMT3,270$12.10$39,5678,617−27.5%10b5-1
Aug 13, 2026 MForm 4 →Aug 17, 5:34 pm EDT4D Molecular Therapeutics, Inc.FDMT3,270$4.14$13,53810,252—10b5-1
Jun 30, 2026 SForm 4 →Jul 2, 4:07 pm EDT4D Molecular Therapeutics, Inc.FDMT6,566$14.00$91,9248,617−43.2%10b5-1
Jun 30, 2026 MForm 4 →Jul 2, 4:07 pm EDT4D Molecular Therapeutics, Inc.FDMT6,566$6.20$40,70015,183—10b5-1
Jun 23, 2026 SForm 4 →Jun 25, 4:38 pm EDT4D Molecular Therapeutics, Inc.FDMT9,810$12.00$117,7208,617−53.2%10b5-1
Jun 23, 2026 MForm 4 →Jun 25, 4:38 pm EDT4D Molecular Therapeutics, Inc.FDMT9,810$4.14$40,61318,427—10b5-1

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Sep 16, 2026 MForm 4 →Sep 22, 6:43 pm EDT4D Molecular Therapeutics, Inc.FDMT1,635——58,066—10b5-1 late
Sep 1, 2026 MForm 4 →Sep 3, 6:55 pm EDT4D Molecular Therapeutics, Inc.FDMT584——2,959—10b5-1
Aug 13, 2026 MForm 4 →Aug 17, 5:34 pm EDT4D Molecular Therapeutics, Inc.FDMT3,270——59,701—10b5-1
Jun 30, 2026 MForm 4 →Jul 2, 4:07 pm EDT4D Molecular Therapeutics, Inc.FDMT6,566——3,543—10b5-1
Jun 23, 2026 MForm 4 →Jun 25, 4:38 pm EDT4D Molecular Therapeutics, Inc.FDMT9,810——63,785—10b5-1